BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11214626)

  • 1. Multiple pituitary hormone gradients from cavernous sinus sampling in patients with Cushing's disease.
    Yoshida Y; Sanno N; Teramoto A
    Acta Neurochir (Wien); 2000; 142(12):1339-44. PubMed ID: 11214626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cavernous sinus sampling in patients with adrenocorticotrophic hormone-dependent Cushing's syndrome with emphasis on inter- and intracavernous adrenocorticotrophic hormone gradients.
    Teramoto A; Yoshida Y; Sanno N; Nemoto S
    J Neurosurg; 1998 Nov; 89(5):762-8. PubMed ID: 9817414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective venous sampling directly from cavernous sinus in Cushing's syndrome.
    Teramoto A; Nemoto S; Takakura K; Sasaki Y; Machida T
    J Clin Endocrinol Metab; 1993 Mar; 76(3):637-41. PubMed ID: 8383143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
    de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease.
    Zovickian J; Oldfield EH; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1988 Feb; 68(2):205-10. PubMed ID: 2828570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective venous sampling from the cavernous sinuses is not a more reliable technique than sampling from the inferior petrosal sinuses in Cushing's syndrome.
    Doppman JL; Nieman LK; Chang R; Yanovski J; Cutler GB; Chrousos GP; Oldfield EH
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2485-9. PubMed ID: 7629247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pituitary hormone gradients from inferior petrosal sinus sampling in Cushing's disease.
    Crock PA; Pestell RG; Calenti AJ; Gilford EJ; Henderson JK; Best JD; Alford FP
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):75-80. PubMed ID: 2842995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
    Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing's disease.
    Schulte HM; Allolio B; Günther RW; Benker G; Winkelmann W; Ohnhaus EE; Reinwein D
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):289-95. PubMed ID: 2844450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of multiple-site venous sampling in the treatment of adrenocorticotropic hormone-producing pituitary adenomas.
    Kai Y; Hamada J; Nishi T; Morioka M; Mizuno T; Ushio Y
    Surg Neurol; 2003 Apr; 59(4):292-8; discussion 298-9. PubMed ID: 12748013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferior petrosal sinus sampling: evidence of a stimulatory effect of oCRH on GH secretion in Cushing's disease.
    Loli P; Vignati F; Scialfa G; Boccardi E; Branca V; Berselli ME
    Acta Endocrinol (Copenh); 1990 Aug; 123(2):238-42. PubMed ID: 2171293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral and simultaneous venous sampling of inferior petrosal sinuses for ACTH and PRL determination: preoperative localization of ACTH-secreting microadenomas.
    Vignati F; Berselli ME; Scialfa G; Boccardi E; Loli P
    J Endocrinol Invest; 1989 Apr; 12(4):235-8. PubMed ID: 2545768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing's disease.
    Landolt AM; Schubiger O; Maurer R; Girard J
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):485-92. PubMed ID: 8187314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location.
    Graham KE; Samuels MH; Nesbit GM; Cook DM; O'Neill OR; Barnwell SL; Loriaux DL
    J Clin Endocrinol Metab; 1999 May; 84(5):1602-10. PubMed ID: 10323387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of super-selective bilateral cavernous sinus sampling with hypothalamic stimulating hormone loading in patients with ACTH-producing pituitary adenoma.
    Fujimura M; Ikeda H; Takahashi A; Ezura M; Yoshimoto T; Tominaga T
    Neurol Res; 2005 Jan; 27(1):11-5. PubMed ID: 15829152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.